Rimidi News & Insights

Category: Inside Views

SMART on FHIR is changing healthcare – Rimidi joins Cerner Marketplace

Rimidi is on fire because of FHIR. We just launched our Diabetes+Me application in Cerner’s app marketplace, an improtant milestone in interoperability for us as a company. Rimidi is a digital health company providing software and clinical analytics for chronic disease management. Our goal is to make it easier for people with diabetes and their healthcare providers to manage […]

The Cost of Complications

Today, diabetes will cause 200 individuals to undergo an amputation, 136 to enter end-stage kidney disease treatment, and 1,795 to develop severe retinopathy that could lead to vision loss and blindness. These complications are key drivers in the direct medical costs of patients with diabetes and account for 20% of total diabetes care spending. Additionally, […]

Diabetes by the Numbers

On average people with diabetes have medical expenditures roughly 2.3 times higher than what they would be in the absence of diabetes. Care for people with diagnosed diabetes accounts for more than 1 in 5 health care dollars in the U.S., and more than half of that can be directly attributed to diabetes. The cost of diabetes […]

MACRA and the Future of Telehealth

In October, the Centers for Medicare and Medicaid Services (CMS) released the Final Rule implementing the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). This rule, which is nearly 2.400 pages in length, is intended to lay the foundation for the future of the Medicare reimbursement system with the intent of rewarding clinicians for […]

Industry awaits FDA rules on how much medicine computers can practice

By Arthur Allen with Politico When policymakers talk about making medicine better, they generally mean getting computers to do more of the work. President Barack Obama’s Precision Medicine Initiative, Vice President Joe Biden’s Cancer Moonshot and the meaningful use program are all about getting software to replace or augment doctorly activities. As medicine moves that […]

Rimidi Demos Diabetes+Me to Congress

Recently, I had the opportunity to visit Capitol Hill to discuss policy issues affecting digital health and demo Rimidi’s Diabetes+Me app to more than 200 Congressional and agency staff. It was a great opportunity to learn more about reimbursement issues affecting digital health and share information with Congressional representatives. ACT | The App Association’s Connected […]

Technology Association of Georgia Unveils the Top 40 Innovative Technology Companies in Georgia

Read this on Metro Atlanta CEO Staff Report From Georgia CEO The Technology Association of Georgia today announced the Top 40 Innovative Technology Companies in Georgia. TAG’S Top 40 Awards recognize Georgia-based technology companies for their innovation, financial impact, and their efforts at spreading awareness of the state’s technology initiatives throughout the U.S. and globally. […]

Rimidi Remedies Chronic Disease with Diabetes+Me

Read this on Hypepotamus Over 29 million people in the United States have diabetes, a chronic disease that remains the 7th leading cause of death in the country. So, in an effort to alleviate the delivery of diabetes care, Atlanta-based Rimidi created Diabetes+Me, a cloud-based platform that identifies and closes gaps in managing the condition – and it’s […]


Read this article on atdc Rimidi a Signature startup company of the Advanced Technology Development Center (ATDC) at Georgia Tech, is among the top three opportunities for health care apps with its Diabetes+Me technology, according to a recent report by ACT The App Association. “Atlanta-based Rimidi is one company showing the path forward with its Diabetes+Me App,” the […]

Mobile diabetes intervention reduced HbA1c 2 percentage points more than standard of care

Read this article on Mobi Health News By Jonah Comstock In late 2014, MobiHealthNews reported that Atlanta-based diabetes management company Rimidi was piloting its software in a 129-patient RCT with Desert Oasis Healthcare, part of Heritage California ACO, a pioneer ACO. Now the company has made public some of the preliminary results from the ongoing study, showing that patients who used Rimidi’s […]

Expanding Pharmacist Provider Status Can Improve Diabetes Management

By Lucienne Ide Multiple studies have shown improved outcomes by placing pharmacists into diabetes management roles. With a chronic condition such as diabetes, which impacts 29 million Americans, that’s welcome news. As the number of people with diabetes continues to escalate, we are faced with not only a physician shortage, but a provider shortage. We […]